In this episode of the Cancer Disparities podcast, Dr Otis Brawley and Dr Curtiland Deville from Sibley Memorial Hospital discuss the range of available treatments for prostate cancer, reducing cancer disparities, and increasing minority representation in radiation oncology.
In this Cancer Matters podcast, Dr Bill Nelson and Dr Emmanuel Antonarakis explain how PARP Inhibitors work and their use in treating some types of prostate cancer.
Aug 6, 2020 No comments
In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Mario Eisenberger about treating advanced-stage prostate cancer.
Jul 23, 2020 No comments
In this week's Cancer Disparities podcast, Dr Otis Brawley speaks with Dr Michael Carducci about the benefit of clinical trials and his work treating patients with prostate cancer.
Jan 8, 2020 No comments
Our next podcast from Dr Akila Viswanathan is now available. Today, she speaks with Dr Curt Deville from Sibley Memorial Hospital in Washington DC about the diagnosis and treatment of prostate cancer and the opening of the Johns Hopkins National Proton Center coming to Sibley later this year. In this preview, Dr Deville describes some of […]
Aug 13, 2019 No comments
In the next Cancer Disparities podcast, Dr Otis Brawley reviews a paper published in JAMA on outcomes for prostate cancer patients based on race and explains that the inequalities revealed are caused by the quality of the care received by the patients. In the preview, Dr Brawley says the key to dealing with this issue […]
Jun 5, 2019 No comments
Dr Ben Levy talks to Dr Channing Paller, medical oncologist at Sibley Memorial Hospital and an assistant professor of oncology at the Johns Hopkins University School of Medicine, about her research into prostate cancer treatments and care.
Jul 12, 2018 No comments
Prostate cancer is a leading health problem for men. As strategies for prostate cancer screening and active surveillance are refined, men may benefit from early detection and cure of life-threatening prostate cancer but avoid overtreatment of the non-life-threatening variety. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American […]
Feb 19, 2018 No comments
“Prostate cancer mortality has been declining since prostate cancer screening started in 1995,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “There’s no question that it works. The problem is diagnosing these cancers in men who aren’t threatened by the disease and then pursuing treatment." "When […]
Jul 6, 2017 No comments
Prostate cancer is extremely common in the U.S. “It’s the most common life-threatening cancer in men, responsible for 26,000 deaths per year,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. But there are a lot of prostate cancers that are not life-threatening, he says. “In autopsies […]
Jun 29, 2017 No comments